Over the last decade the discovery of genetic testing for breast cancer susceptibility genes (such as BRCA1 & BRCA2) has seen a rise in preemptive screening in many countries, particularly where a strong family history of breast cancer has been observed [36,37] (Figure 1). The gene discussed is BRCA2; the disease is breast carcinoma.